位元堂薬業に関するコメント

The market views the company's poor revenue performance as a potential future underperformance. Despite strong three-year revenue trends, shareholders seem to think recent performance has peaked, accepting lower selling prices. There may be significant risks to the company's profitability, possibly pressuring the P/S ratio.